Pregnancy disorder with abortive outcome

disease
On this page

Also known as intrauterine fetal deathintrauterine fetal demiseIUFDpregnancy with abortive outcomestillbirth

Summary

Pregnancy disorder with abortive outcome (MONDO:0041526) is a disease and 73 clinical trials. Top therapeutic interventions include epoetin beta, folic acid, and mifepristone. A subtype of pregnancy disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 73

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namepregnancy disorder with abortive outcome
Mondo IDMONDO:0041526
ICD-10-CMO00-O08
SNOMED CT363681007
UMLSC0156543
MedGen102352
Is cancer (heuristic)no

Also known as: intrauterine fetal death · intrauterine fetal demise · IUFD · pregnancy with abortive outcome · stillbirth

Disease family

This is a subtype of pregnancy disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › obstetric disorderpregnancy disorderpregnancy disorder with abortive outcome

Related subtypes (28): funisitis, chorea gravidarum, luteoma of pregnancy, polyhydramnios, impetigo herpetiformis, gestational diabetes, placenta disorder, pemphigoid gestationis, dystocia, hyperemesis gravidarum, pruritic urticarial papules and plaques of pregnancy, familial gestational hyperthyroidism, pseudohyperaldosteronism type 2, aromatase deficiency, acute fatty liver of pregnancy, malignancy diagnosed during pregnancy, postpartum psychosis, peripartum cardiomyopathy, gestational trophoblastic neoplasm, hypertension, pregnancy-induced, chronic intervillositis of unknown etiology, postpartum amenorrhea-galactorrhea syndrome, pregnancy associated osteoporosis, twin anemia-polycythemia sequence, twin-reversed arterial perfusion sequence, selective intrauterine growth restriction, amniotic fluid embolism, vasa previa

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 73.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified65
PHASE34
PHASE43
PHASE2/PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT05757167PHASE4ACTIVE_NOT_RECRUITINGImproving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
NCT00270530PHASE4COMPLETEDIntermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
NCT02620904PHASE4TERMINATEDMifepristone Induction for Fetal Demise
NCT06723392PHASE3RECRUITINGAsymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
NCT07537894PHASE2/PHASE3NOT_YET_RECRUITINGPerioperative Dexmedetomidine to Reduce Post-procedure Grief Following Second-trimester Dilation and Evacuation
NCT00133744PHASE3COMPLETEDImpact of Prenatal Vitamin/Mineral Supplements on Perinatal Mortality
NCT00671060PHASE3COMPLETEDMisoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
NCT02336243PHASE3UNKNOWNA Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
NCT02738892Not specifiedACTIVE_NOT_RECRUITINGZambian Preterm Birth Prevention Study
NCT03662178Not specifiedRECRUITINGInvestigating the Structured Use of Ultrasound Scanning for Fetal Growth
NCT03775954Not specifiedRECRUITINGFetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
NCT04393259Not specifiedRECRUITINGThe Tommy’s National Rainbow Clinic Study
NCT04905537Not specifiedRECRUITINGStudy on Early Genetic Screening and Precise Strategy of Neonatal Critical Illness
NCT06125860Not specifiedACTIVE_NOT_RECRUITINGBEP Targeting Strategies in Ethiopia
NCT06273007Not specifiedRECRUITINGImproving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach
NCT06825481Not specifiedNOT_YET_RECRUITINGUterine Doppler As StillbirthPredictor
NCT06918236Not specifiedRECRUITINGAssociation of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
NCT07011940Not specifiedNOT_YET_RECRUITINGWalk With Me (WWM) for Perinatal Grief
NCT07015203Not specifiedRECRUITINGThe Combined First Trimester Screening
NCT07144839Not specifiedRECRUITINGPlacental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
NCT07494760Not specifiedNOT_YET_RECRUITINGA Feasibility Randomised Control Trial to Evaluate Early Perinatal Bereavement Counselling for Parents Who Have Experienced a Perinatal Death
NCT00573118Not specifiedUNKNOWNSevere Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity
NCT00856076Not specifiedUNKNOWNVenous Thromboembolism in Pregnancy Study
NCT00878098Not specifiedCOMPLETEDStudy of DDT and Loss of Clinically-Recognized Pregnancies in South Africa
NCT01229189Not specifiedCOMPLETEDEvaluation of the Effectiveness of Vitamin D Supplementation to Pregnant Women and Their Infants in Pakistan.
NCT01417962Not specifiedCOMPLETEDMagnetic Resonance Imaging Autopsy Study
NCT01664546Not specifiedUNKNOWNStudy of the Best Blastocyst Post Transfer by aCGH
NCT01777022Not specifiedCOMPLETEDPromoting Awareness Fetal Movements to Reduce Fetal Mortality Stillbirth, a Stepped Wedge Cluster Randomised Trial.
NCT01867749Not specifiedCOMPLETEDGroup Interpersonal Psychotherapy for Treatment of Major Depressive Disorder Following Perinatal Loss
NCT01888380Not specifiedCOMPLETEDThe Paediatric Virtual Autopsy Trial
NCT01916928Not specifiedCOMPLETEDThe Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
NCT01990625Not specifiedCOMPLETEDA Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country Settings
NCT01995968Not specifiedUNKNOWNAntenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
NCT02025530Not specifiedCOMPLETEDThe Midlands and North of England Stillbirth Study
NCT02039583Not specifiedCOMPLETEDImpact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in England
NCT02148952Not specifiedCOMPLETEDBetterBirth: A Trial of the WHO Safe Childbirth Checklist Program
NCT02185625Not specifiedCOMPLETEDReduction of Adverse Pregnancy Outcomes With a Smartphone Application in Ghana
NCT02189265Not specifiedCOMPLETEDAssessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands
NCT02218931Not specifiedCOMPLETEDESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
NCT02273037Not specifiedCOMPLETEDIntermittent Auscultation Using Handheld Doppler: a Randomized Controlled Trial Comparing Perinatal Outcomes in Uganda

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
EPOETIN BETA41
FOLIC ACID41
MIFEPRISTONE41